Potentiation of oncolytic virotherapy with armed shRNA.
Guo
Wei
W
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA.
Fang
Bingliang
B
D000256:Adenoviridae / Q000235:genetics*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017930:Genes, Reporter; D005818:Genetic Engineering; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D050130:Oncolytic Virotherapy / Q000379:methods*; D050504:Oncolytic Viruses / Q000235:genetics; D034622:RNA Interference; D019098:Telomerase / Q000235:genetics*; D014765:Viral Vaccines
D000970:Antineoplastic Agents; D014765:Viral Vaccines; C464532:dl1520; D019098:Telomerase